Masimo to Report Fourth Quarter and Full Year 2012 Financial Results after Market Close on Thursday, February 14

  Masimo to Report Fourth Quarter and Full Year 2012 Financial Results after
                    Market Close on Thursday, February 14

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)

PR Newswire

IRVINE, Calif., Jan. 30, 2013

IRVINE, Calif., Jan. 30, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced
today that it will release fourth quarter and full year 2012 financial results
for the period ended December 29, 2012, after the market closes on Thursday,
February 14, 2013. The conference call to review the results will begin at
1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and
Chief Executive Officer, and Mark P. de Raad, Executive Vice President and
Chief Financial Officer.

A live webcast of the conference call will be available online from the
investor relations page of the company's corporate website at www.masimo.com.
The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706)
758-3929 for international callers. The reservation code for both dial-in
numbers is 92598385. After the live webcast, the call will be available on
Masimo's website through March 14, 2013. In addition, a telephonic replay of
the call will be available through February 28, 2013. The replay dial-in
numbers are (800) 585-8367 for domestic callers and +1 (855) 859-2056 for
international callers. Please use reservation code 92598385.

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive
monitoring technologies that significantly improve patient care—helping solve
"unsolvable" problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET^®, which virtually
eliminated false alarms and increased pulse oximetry's ability to detect
life-threatening events. More than 100 independent and objective studies have
shown that Masimo SET^® outperforms other pulse oximetry technologies, even
under the most challenging clinical conditions, including patient motion and
low peripheral perfusion. In 2005, Masimo introduced rainbow SET^® Pulse
CO-Oximetry technology, allowing noninvasive and continuous monitoring of
blood constituents that previously required invasive procedures, including
total hemoglobin (SpHb^®), oxygen content (SpOC™), carboxyhemoglobin (SpCO^®),
methemoglobin (SpMet^®), and Pleth Variability Index (PVI^®), in addition to
SpO[2], pulse rate, and perfusion index (PI). In 2008, Masimo introduced
Patient SafetyNet™, a remote monitoring and wireless clinician notification
system designed to help hospitals avoid preventable deaths and injuries
associated with failure to rescue events. In 2009, Masimo introduced rainbow^®
Acoustic Monitoring™, the first-ever noninvasive and continuous monitoring of
acoustic respiration rate (RRa™). Masimo's rainbow^® SET^® technology
platform offers a breakthrough in patient safety by helping clinicians detect
life-threatening conditions and helping guide treatment options. In 2010,
Masimo acquired SEDLine^®, a pioneer in the development of innovative brain
function monitoring technology and devices. And in 2012, Masimo acquired the
assets of Spire Semiconductor, LLC, maker of advanced light emitting diode
(LED) and other advanced component-level technologies; and PHASEIN AB, a
developer and manufacturer of ultra-compact mainstream and sidestream
capnography, multigas analyzers, and handheld capnometry solutions. Masimo
SET^® and Masimo rainbow^® SET^® technologies also can be found in over 100
multiparameter patient monitors from over 50 medical device manufacturers
around the world. Founded in 1989, Masimo has the mission of "Improving
Patient Outcome and Reducing Cost of Care … by Taking Noninvasive Monitoring
to New Sites and Applications^®." Additional information about Masimo and its
products may be found at www.masimo.com.

Contact:
Sheree Aronson
(949) 297-7043
saronson@masimo.com

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and
Reducing Cost of Care… by Taking Noninvasive Monitoring to New Sites and
Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Rainbow Acoustic
Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry,
Pulse CO-Oximeter, and SEDLine are trademarks or registered trademarks of
Masimo Corporation.

SOURCE Masimo Corporation

Website: http://www.masimo.com
 
Press spacebar to pause and continue. Press esc to stop.